The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair
Abstract
The essential checkpoint kinase Chk1 is required for cell-cycle delays after DNA damage or blocked DNA replication. However, it is unclear whether Chk1 is involved in the repair of damaged DNA. Here we establish that Chk1 is a key regulator of genome maintenance by the homologous recombination repair (HRR) system. Abrogation of Chk1 function with small interfering RNA or chemical antagonists inhibits HRR, leading to persistent unrepaired DNA double-strand breaks (DSBs) and cell death after replication inhibition with hydroxyurea or DNA-damage caused by camptothecin. After hydroxyurea treatment, the essential recombination repair protein RAD51 is recruited to DNA repair foci performing a vital role in correct HRR. We demonstrate that Chk1 interacts with RAD51, and that RAD51 is phosphorylated on Thr 309 in a Chk1-dependent manner. Consistent with a functional interplay between Chk1 and RAD51, Chk1-depleted cells failed to form RAD51 nuclear foci after exposure to hydroxyurea, and cells expressing a phosphorylation-deficient mutant RAD51(T309A) were hypersensitive to hydroxyurea. These results highlight a crucial role for the Chk1 signalling pathway in protecting cells against lethal DNA lesions through regulation of HRR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both Chk1 and Chk2 regulate the functional associations between BRCA1, BRCA2, and Rad51 proteins in response to DNA damage, and thus promote HR-mediated repair of stalled replication forks [27, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [27]
In the citing paper
“Moreover, both the ATR-Chk1 and ATM-Chk2 pathways regulate HR-mediated repair of collapsed replication forks [27, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [27]
In the citing paper
“activated Chk1 phosphorylates its own substrates such as protein Rad51, which is involved in the DSB repair by HR [193–195]”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [195]
Citations
Cites
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Sensing and repairing DNA double-strand breaks
Jackson, S. P. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.687 · Cited by 1,149
ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1
Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091
(1999) · PubMed · Cited by 1,030
Molecular views of recombination proteins and their control
West, S. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1127 · Cited by 977
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Rad51‐deficient vertebrate cells accumulate chromosomal breaks prior to cell death
Sonoda, E., Sasaki, M., Buerstedde, J., Bezzubova, O., Shinohara, A., Ogawa, H., Takata, M., Yamaguchi-Iwai, Y., & Takeda, S. (1998) · EMBO Journal · doi:10.1093/emboj/17.2.598 · Cited by 860
Targeted disruption of the Rad51 gene leads to lethality in embryonic mice.
Tsuzuki, T., Fujii, Y., Sakumi, K., Tominaga, Y., Nakao, K., Sekiguchi, M., Matsushiro, A., Yoshimura, Y., & MoritaT (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6236 · Cited by 792
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 662
Targeting ATR in Cancer Medicine
Salguero, C., Valladolid, C., Robinson, H. M. R., Smith, G. C. M., & Yap, T. A. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-30065-3_14 · Cited by 6
Accumulation of sumoylated Rad52 in checkpoint mutants perturbed in DNA replication
Ohuchi, T., Seki, M., Kugou, K., Tada, S., Ohta, K., & Enomoto, T. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.018 · Cited by 5
Li, L., Wang, L., Liu, D., & Zhao, Y. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01611-x · Cited by 5
Combination DNA Damage Response (DDR) Inhibitors to Overcome Drug Resistance in Ovarian Cancer
Nasioudis, D., George, E. M., Xu, H., Kim, H., & Simpkins, F. A. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-30065-3_11 · Cited by 5
Li, J., Tang, Y., Huang, L., Yu, Q., Hu, G., Chen, C., Zhang, P., & Yuan, X. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1670-z · Cited by 5
Woo, T.-T., Chuang, C.-N., & Wang, T. (2021) · Current Genetics · doi:10.1007/s00294-020-01151-2 · Cited by 5
DNA Damage, Repair and Misrepair in Cancer and in Cancer Therapy
Ana, M., Ferreira, L. M. R., Joana, F., Carlos, F., & Maria, C. (2011) · InTech eBooks · doi:10.5772/23190 · Cited by 5
Preclinical Profiles and Contexts for CHK1 and CHK2 Inhibitors
Collins, I., & Garrett, M. D. (2018) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-75836-7_10 · Cited by 5
Impact of Chk1 dosage on somatic hypermutation in vivo
Bello, A., & Jungnickel, B. (2021) · Immunology and Cell Biology · doi:10.1111/imcb.12480 · Cited by 5
Abdelfattah, A., Habib, A., Thomas, L.-A., Menendez-Gonzalez, J. B., Almotiri, A., Alqahtani, H., Lawson, H., Taha, S., Steadman, M., Athalye, R., et al. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102596 · Cited by 4
MCL‐1 interacts with MOF and BID to regulate H4K16 acetylation and homologous recombination repair
Mattoo, A. R., & Jessup, J. M. (2022) · Cell Biology International · doi:10.1002/cbin.11831 · Cited by 4
Meng, F., Qi, T., Liu, X., Wang, Y., Yu, J., Lu, Z., Cai, X., Li, A., Jung, D. T., & Duan, J. (2024) · International Journal of Cancer · doi:10.1002/ijc.35170 · Cited by 5
Dewdney, B., Miranda, P. J., Kuchibhotla, M., Palanisamy, R., Richworth, C. M., Milligan, C. J., Ng, Z. Y., Ursich, L. T., Petrou, S., Fletcher, E. V., et al. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae187 · Cited by 5
Etingov, I., & Pintel, D. J. (2024) · Journal of Virology · doi:10.1128/jvi.00889-24 · Cited by 4
Wang, Y., & Wang, H. (2004) · Humana Press eBooks · doi:10.1385/1-59259-811-0:143 · Cited by 4
Emerging Concepts in Neuro-Oncology
Sciuscio, D., & Hegi, M. E. (2012) · Springer eBooks · doi:10.1007/978-0-85729-458-6 · Cited by 5
Sakamoto‐Hojo, E. T., Mello, S. S., Bassi, C. L., Merchi, I. M., Carminati, P. O., Fachin, A. L., Donadi, E. A., & Passos, G. A. S. (2005) · Genome dynamics and stability · doi:10.1007/7050_010 · Cited by 4
Kim, S.-Y., Kim, G.-Y., You, H.-J., & Kang, M. (2021) · Animal Bioscience · doi:10.5713/ab.21.0117 · Cited by 4
Yasuhira, S., Saito, T. H., Maesawa, C., & Masuda, T. (2012) · DNA repair · doi:10.1016/j.dnarep.2012.05.006 · Cited by 4
Kong, L., Li, H. X., Wu, D., Xu, G. R., Wang, D. L., & Zhao, Y. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15026132 · Cited by 4
The DNA Damage Response: Roles in Cancer Etiology and Treatment
Butler, L. R., Gilad, O., & Brown, E. J. (2018) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-75836-7_2 · Cited by 4
Inhibition of DNA Repair as a Therapeutic Target
Veuger, S. J., & Curtin, N. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00008-5 · Cited by 4
Checkpoint kinase 1 is activated and promotes cell survival after exposure to sulphur mustard
Jowsey, P. A., & Blain, P. G. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.11.013 · Cited by 4
Radiosensitizers in Cancer Therapy: A Global Bibliometric Analysis
Annagiri, S., Harary, P. M., Hori, Y. S., Lam, F. C., AbuReesh, D., Tayag, A., Ustrzynski, L., Emrich, S. C., Chang, S. D., & Park, D. J. (2025) · doi:10.1101/2025.06.26.661878 · Cited by 3
PCAF-mediated acetylation regulates RAD51 dynamic localization on chromatin during HR repair
Hou, J., Shi, M., Hong, J., Liu, Y., Song, X., Rao, H., Ma, Y., Huang, C., Hu, Z., He, L., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00513-6 · Cited by 3
Zhang, X., Yuan, G., Chen, Y., Xu, Y., Liu, T., Zhao, Q., & Li, S. (2025) · Advanced Biology · doi:10.1002/adbi.202500246 · Cited by 3
Li, T., Xia, X., Kong, S., Wang, T., Fan, F., & Wang, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107091 · Cited by 3
CKS1B regulates the radiosensitivity of lung cancer via activating the PI3K/AKT signaling pathway
Lu, J., Du, L., Zhang, P., Ma, N., Zhang, Q. Y., Guo, X., Li, X., Lei, X., & Qu, B. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111828 · Cited by 3
RAD51 Is a Key Protein of DNA Repair and Homologous Recombination in Humans
Mazin, A. V., & Mazina, O. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4741-2_12 · Cited by 3
Etingov, I., & Pintel, D. J. (2024) · Journal of Virology · doi:10.1128/jvi.00559-24 · Cited by 3
Radiosensitization to γ-Ray by Functional Inhibition of APOBEC3G
Tong, Y., Kikuhara, S., Onodera, T., Chen, L., Myat, A. B., Imamichi, S., Sasaki, Y., Murakami, Y., Nozaki, T., Fujimori, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095069 · Cited by 3
Faithful DNA Replication Requires Regulation of CDK Activity by Checkpoint Kinases
Storgaard, C. D., Beck, H., Nähse, V., & Randi, G. (2011) · InTech eBooks · doi:10.5772/18616 · Cited by 3
Yu, X., Wang, H., Liu, S., Zhang, X., Guida, P. M., Hu, B., & Wang, Y. (2010) · Cell Cycle · doi:10.4161/cc.9.10.11651 · Cited by 3
Romanova, L. Y., Mushinski, F., & Kovalchuk, A. L. (2018) · Oncotarget · doi:10.18632/oncotarget.25172 · Cited by 3
Towards finding the complete modulome: density constrained biclustering
Çolak, R. (2008) · Summit (Simon Fraser University) · Cited by 3
Claspin and Cancer: Where Are We Now?
Azenha, D., & Martins, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188828 · Cited by 2
Replication stress in cancer: origins, consequences and therapeutic opportunities
Chen, J., & Zou, L. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00979-z · Cited by 2
Targeting DNA Repair Pathways for Cancer Therapy
Vens, C., & Sobol, R. W. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5847-0_6 · Cited by 2
Improving the Therapeutic Ratio of Radiotherapy by Targeting the DNA Damage Response
Carruthers, R., & Chalmers, A. J. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-40854-5_1 · Cited by 2
Crosstalk Between Plk1 and PTEN in Mitosis Affects Chromosomal Stability
Li, W., Wang, X., Liu, J., Liu, B., & Hao, Y. (2025) · DNA and Cell Biology · doi:10.1089/dna.2024.0246 · Cited by 2
Ling, H. Y., Li-Feng, L., Ling, W. E. N., He, J., Hui, T. A. N., Xia, H., & Su, Q. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2009.00469 · Cited by 2
Collin, R., Doyon, K., Mullins‐Dansereau, V., Karam, M., Chabot‐Roy, G., Hillhouse, E. E., Orthwein, A., & Lesage, S. (2018) · Immunogenetics · doi:10.1007/s00251-018-1060-8 · Cited by 2
Targeting acute myeloid leukemia CD34+ stem/progenitor cells with small molecule inhibitor MK-8776
Lei, H., Li, Y., Zhou, L., Tong, Y., & Wu, Y. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.08.003 · Cited by 2
DNA Repair Pathways and Human Cancer
D’Andrea, A. D. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10004-4 · Cited by 2
Targeting DNA Damage Response Pathways in Cancer
Abdulrahman, G. O., & Curtin, N. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12394-7 · Cited by 2
Slow Evolution of rag1 and pomc Genes in Vertebrates with Large GenomesPreprint
Sclavi, B., & Herrick, J. (2013) · arXiv (Cornell University) · doi:10.48550/arxiv.1302.2182 · Cited by 2
Woo, T.-T., Chuang, C.-N., & Wang, T. (2021) · Current Genetics · doi:10.1007/s00294-021-01161-8 · Cited by 2
Kee, Y., Lee, J.-H., & You, H. J. (2022) · Molecular & Cellular Oncology · doi:10.1080/23723556.2022.2054263 · Cited by 2
Synthetic Lethality with Homologous Recombination Repair Defects
Bryant, H. E., & Shall, S. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-14151-0_13 · Cited by 1
Rucaparib for the treatment of ovarian cancer
Cyriac, S. L., Karakasis, K., & Oza, A. M. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1419129 · Cited by 1
Duabil, A. J., Cooper, C. R., Aldujaily, E., Halford, S. E. R., Hirschberg, S., KATUGAMPOLA, S. D., & Jones, G. D. D. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00193 · Cited by 1
Liu, N., Shen, C., Zhou, T., Zhou, Y., Yuan, H., Bi, H., Wang, Y., Pei, X., Su, R. J., Trisal, V., et al. (2026) · Cancer & Metabolism · doi:10.1186/s40170-026-00435-4 · Cited by 1
PARG inhibition reduces ssDNA levels and limits RPA loading upon replication fork collapse
Mihuț, A., Ghosh, D., Kószó, A., Szüts, D., Salajkova, S. A., Andrš, M., Dobrovolná, J., Fajka‐Boja, R., & Timinszky, G. (2026) · EMBO Reports · doi:10.1038/s44319-026-00848-8 · Cited by 1
In Vitro Models of Brain Cancer
Ryan, D. J., & Watts, C. (2012) · Springer eBooks · doi:10.1007/978-0-85729-458-6_5 · Cited by 1
Homologous Recombination in Mammals
Barascu, A., Grabarz, A., & López, B. S. (2012) · Topics in current genetics · doi:10.1007/978-94-007-4531-5_4 · Cited by 1
p53-driven replication stress in nucleoli of malignant epithelial ovarian cancer
Guo, C. Y., Guo, L., Peng, C., Jia, Y., Yang, Y., Wang, X., Zeng, M., Wang, D., Liu, C., Zhao, M., et al. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113225 · Cited by 1
Ye, F., Yang, Z., Liu, Y., Gong, D., Ji, T., Wang, J., Xi, B. X., Zhou, J., Ma, D., & Gao, Q. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2014.20 · Cited by 1
Targeting Myc-driven tumours - BETing on ATR
Muralidharan, S. V. (2016) · Cited by 1
Targeting CHK1 for Cancer Therapy: Rationale, Progress and Prospects
Gillespie, D. A. (2018) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-75836-7_9 · Cited by 1
Checkpoint Control Following Radiation Exposure
Löbrich, M., Goodarzi, A. A., Stiff, T., & Jeggo, P. A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8044-1_3 · Cited by 1
Combining Chk1/2 inhibition with radiation in head and neck cancer
Nikolaev, A. Y., & Yang, E. S.-H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817868-3.00014-7 · Cited by 1
Targeting the DNA Damage Response for Radiosensitization
McMillan, M. T., Lawrence, T. S., & Morgan, M. A. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_9 · Cited by 1
Wang, H. Y., & Wang, Y. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-998-3_39 · Cited by 1
KRCC1, a modulator of the DNA damage response
Neizer‐Ashun, F., Dwivedi, S. K. D., Dey, A., Thavathiru, E., Berry, W. L., Lees‐Miller, S. P., Mukherjee, P., & Bhattacharya, R. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac890 · Cited by 1
The DNA Damage Response, DNA Repair, and AML
Steensma, D. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_5 · Cited by 1
Characterisation of the role of autophagy in DNA damage repair
Liu, E. Y. (2014) · Enlighten: Theses (The University of Glasgow) · Cited by 1
The kinase MK2 in DNA replication upon genotoxic stress and chemotherapy
Köpper, F. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1445 · Cited by 1
Investigating the role of NSMCE2 in cell cycle progression and genome maintenance
Dixon, L. (2018) · Lancaster EPrints (Lancaster University) · doi:10.17635/lancaster/thesis/509 · Cited by 1
van der Wiel, A. M.-M. A. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230202aw · Cited by 1
Middleton, F. K., & Curtin, N. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4741-2_10
Germline Mutations in CHEK1 and CHEK2 in Women with Ovarian, Peritoneal, or Fallopian Tube Cancer
Harrell, M. I. (2015) · ScholarWorks (Walden University)
Matthews, D. J., & Gerritsen, M. E. (2010) · Wiley eBooks · doi:10.1002/9780470555293.ch6
The Relationship Between Replication and Recombination
Bedina, A. (2011) · InTech eBooks · doi:10.5772/18485
Replication fork stability in mammalian cells
Elvers, I. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Lima, L. C. D. A. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-28112014-100235
Involvement of p53 in the S-phase Checkpoint during Nucleotide Deficiencies
Heyer, C. L. (2011) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/4zf5-2439
Die Beteiligung von Nek1 an der Homologen Rekombination
Spies, J. (2015) · Technischen Universität Darmstadt · doi:10.26083/tuprints-00004423
Hashash, N. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Inhibitors of DNA Repair and Response to Ionising Radiation
Vischioni, B., Nicolay, N. H., Sharma, R. A., & Helleday, T. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8044-1_7
Self-citationRole of checkpoint kinase 1 in malignant melanoma
Smith, J. (2013) · Enlighten: Theses (The University of Glasgow)
Caractérisation et rôle de la phosphorylation de la protéine Rad51
Popova, M. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Keeping replicative stress in Chk
Brooks, K. M., & Gabrielli, B. G. (2012) · Cell Cycle · doi:10.4161/cc.20425
Functions of the MRE11-RAD50-NBS1 complex in DNA double strand break repair
Konkow, S. (2012) · DuEPublico (University of Duisburg-Essen)
Carminati, P. O. (2005) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2005.tde-21082007-103139
Aberrations of DNA Damage in Checkpoints in Cancer
Laiho, M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-200-7_5
Selective targeting of cancer cells through inhibition of Checkpoint kinase 1
Hasvold, G. (2012) · NORA - Norwegian Open Research Archives
Sawant, A. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Signaling of DNA Replication Stress Through the ATR Checkpoint
Shiotani, B., & Zou, L. (2016) · Springer eBooks · doi:10.1007/978-4-431-55873-6_16 · Cited by 1
An evaluation of the checkpoint kinase inhibitor V158411
Stephens, P. (2015)
DSB Repair by Cell-Cycle Signaling and the DNA Damage Response, Regulation of
Marini, F., & Pellicioli, A. (2018) · Springer eBooks · doi:10.1007/978-1-4614-1531-2_76
Vázquez-Villaseñor, I. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Hamed, H. A. (2018) · ORCA Online Research @Cardiff (Cardiff University)
Regulation of DSB Repair by Cell Cycle Signaling and the DNA Damage Response
Marini, F., & Pellicioli, A. (2014) · Springer eBooks · doi:10.1007/978-1-4614-6436-5_76-2
ATR Inhibitors as Potent Modulators of DNA End Resection CapacityPreprint
Dibitetto, D., Sims, J. R., Ascenção, C. F. R., Feng, K., Freire, R., & Smolka, M. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.13.905059
Feu, S. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
RECQL4; Linking DNA Replication and Bone Tumourigenesis
Author, U. (2019) · Lincoln Repository (University of Lincoln) · doi:10.24385/lincoln.24326188
Role of 5-FU in DNA double strand break repair for improved targets in colorectal cancer therapy
Srinivas, U. S. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5025
Metadata
- Authors
- Sørensen, C. S., Hansen, L. T., Dziegielewski, J., Syljuåsen, R. G., Lundin, C., Bartek, J., & Helleday, T.
- Affiliations
- Danish Cancer Society (DK)
- University of Copenhagen (DK)
- University of Sheffield (GB)
- Stockholm University (SE)
- Corresponding author
- Helleday, Thomas
- Venue
- Nature Cell Biology
- Published
- 2005-01-23
- Volume
- 7
- Issue
- 2
- Pages
- 195-201
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2149795092
- Cited by
- 666
- References
- 33
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 18 · 2023: 38 · 2022: 26 · 2021: 38 · 2020: 41 · 2019: 23 · 2018: 31 · 2017: 31 · 2016: 37 · 2015: 44 · 2014: 37 · 2013: 35 · 2012: 48
- FWCI
- 11.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Chk1, homologous recombination repair, RAD51, DNA double-strand break repair, DNA damage response, cell cycle checkpoints, hydroxyurea, camptothecin, genome maintenance, replication inhibition
- MeSH terms
- Checkpoint Kinase 1, Animals, Camptothecin, DNA, DNA Damage, DNA Repair, DNA-Binding Proteins, Cricetinae, Humans, Hydroxyurea, Protein Kinases, Recombination, Genetic, Signal Transduction, Rad51 Recombinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review